Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 4/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL533830 | 1.00 | SLC6A5 (0.52) | SLC6A5FAAHTERTPTPN1PPARG | |
| SCHEMBL29077348 | 1.00 | SLC6A5 (0.52) | SLC6A5FAAHTERTPTPN1PPARG | |
| Hydrochloric Acid SCHEMBL1828097 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| Bromide SCHEMBL29058708 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| Hydrochloric Acid SCHEMBL28566602 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| Hydrochloric Acid SCHEMBL1773161 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| Hydrochloric Acid SCHEMBL14060920 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| Hydrochloric Acid SCHEMBL20258167 | 0.99 | SLC6A5 (0.51) | SLC6A5FAAHTERTPTPN1PPARG | |
| SCHEMBL625634 | 0.91 | MAPK1 (0.47) | SLC6A5CYP1A2MAPTCYP2C19BLM | |
| SCHEMBL725613 | 0.91 | MAPK1 (0.47) | SLC6A5CYP1A2MAPTCYP2C19BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122055137-A | Nanoparticles and formulations thereof for delivery of therapeutic agents throughout the central nervous system | 伊莱利利公司 | 2026-05-15 | — | — | CN | claimed |
| CN-112638362-B | Dry powder formulations of messenger RNA | 川斯勒佰尔公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025103294-A1 | FUSION PROTEIN AND USE THEREOF | 维康平生(北京)生物科技有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-119923272-A | Methods for enhancing immunity | 萨纳度生物公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119497629-A | Nucleic acids encoding constitutively active cyclic GMP-AMP synthases and immunogenic delivery vehicles therefor | 科纳治疗公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119497627-A | Replicon compositions and methods of using the same for treating diseases | 生物技术公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119486767-A | Mitochondria as targeted delivery platform | 赛尔维股份公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119451694-A | MRNA encoding constitutively active cyclic GMP-AMP synthase and lipid delivery vehicles therefor | 科纳治疗公司 | 2025-02-14 | — | — | CN | claimed |
| US-20250009861-A1 | ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF | CHA VACCINE RESEARCH INSTITUTE CO., LTD (KR) | 2025-01-09 | — | — | US | claimed |
| CN-119212713-A | Novel RNA and DNA immunization techniques for combating alphaviruses and other new and epidemic viruses | 梅迪根股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-20180133154-A1 | DECOY NUCLEIC ACID CATIONIC LIPOSOME CARRIER AND PREPARATION METHOD THEREOF | JIANGSU KEYGEN BIOTECH CORP., LTD. (CN) | 2018-05-17 | — | — | US | claimed |
| WO-2017201352-A1 | MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| WO-2017201350-A1 | POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | claimed |
| CN-107106421-A | Mixed multilayer nanostructure of epidermal growth factor and liposome and manufacturing method thereof | 赛特瑞恩股份有限公司 | 2017-08-29 | — | — | CN | claimed |
| EP-0904100-B1 | CATIONIC LIPID AND RECEPTOR LIGAND-FACILITATED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | CHENG PI-WAN (US) | 2006-07-26 | — | — | EP | claimed |
| EP-0904100-A4 | RECEPTOR LIGAND-FACILITATED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | CHENG PI WAN (US) | 2002-01-09 | — | — | EP | claimed |
| US-6077834-A | COMBINING NON-VIRAL RECEPTOR LIGAND AND CATIONIC LIPID ; ADDING POLYNUCLEOTIDE TO FORM MOLECULAR MIXTURE; INTRODUCING MOLECULAR MIXTURE TO CELL TO ENHANCE DELIVERY OF POLYNUCLEOTIDE TO CELL | CHENG PI-WAN (US) | 2000-06-20 | — | — | US | claimed |
| EP-0904100-A1 | RECEPTOR LIGAND-FACILITATED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | Cheng, Pi-Wan (US) | 1999-03-31 | — | — | EP | claimed |
| CN-1160357-A | Gas filled microspheres as computed tomography contrast agents | IMARX PHARMACEUTICAL CORP (US) | 1997-09-24 | — | — | CN | claimed |
| WO-1997028817-A1 | RECEPTOR LIGAND-FACILITATED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | CHENG PI WAN (US) | 1997-08-14 | — | — | WO | claimed |